Testing effectiveness (Phase 2)Study completedNCT00135577
What this trial is testing
Study 767905/008 Extension Study: Alvimopan for Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
Who this might be right for
CancerBowel Dysfunction
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 67